Mondou, Elsa

Publishing since 2003 (Junior)

Has published 12 publications in 6 years

Number of publications published per year by Mondou, Elsa. (Source : PubMed)

Distribution of publications types for Mondou, Elsa. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N. Engl. J. Med. 2008;359;23
Wu IC, Shiffman ML, Tong MJ, Marcellin P, Mondou E, Frederick D, Snow-Lampart A, Sorbel J, Rousseau F, Chang TT. Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants. Clin. Infect. Dis. 2008;47;10
Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology 2008;47;6
Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. Antivir. Ther. (Lond.) 2007;12;5
Bartlett JA, Fath MJ, Demasi R, Hermes A, Quinn J, Mondou E, Rousseau F. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS 2006;20;16
Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B. Arch. Intern. Med. 2006;166;1
Mondou E, Sorbel J, Anderson J, Mommeja-Marin H, Rigney A, Rousseau F. Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine. Clin. Infect. Dis. 2005;41;5
Gish RG, Trinh H, Leung N, Chan FK, Fried MW, Wright TL, Wang C, Anderson J, Mondou E, Snow A, Sorbel J, Rousseau F, Corey L. Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study. J. Hepatol. 2005;43;1
Benson CA, van der Horst C, Lamarca A, Haas DW, McDonald CK, Steinhart CR, Rublein J, Quinn JB, Mondou E, Rousseau F. A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS 2004;18;17
Saag MS, Cahn P, Raffi F, Wolff M, Pearce D, Molina JM, Powderly W, Shaw AL, Mondou E, Hinkle J, Borroto-Esoda K, Quinn JB, Barry DW, Rousseau F. Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial. JAMA 2004;292;2

[ See timeline ] [ See all publications ]

h=16

means that Mondou, Elsa has 16 papers cited a least 16 times - methodology

Key figures

12 pub in 6 years
2.0 publications/year
best year 2004 with 3 pub
h-index 16 with 12 pub
h-ratio : 133 %

See Timeline

Ranking

It's me !

Click here if you are
Mondou, Elsa.

Most frequent Journals

Hepatology (3x)
Clin. Infect. Dis. (2x)
AIDS (2x)
J. Hepatol. (1x)
N. Engl. J. Med. (1x)

Main affiliation

Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.

Latest co-workers

Anderson J Blum MR Frederick D Germanidis G Krastev Z Lau GK Lee SS Marcellin P Mommeja-Marin H Quinn J Quinn JB Rigney A Rousseau F Saag MS Shiffman ML Snow A Snow-Lampart A Sorbel J Trinh H Washington MK

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.